NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Fundamental Analysis
Europe - FRA:NZM2 - DK0060336014 - Common Stock
54.68 EUR
+0.06 (+0.11%)
Overall NZM2 gets a fundamental rating of 4 out of 10. We evaluated NZM2 against 69 industry peers in the Chemicals industry. NZM2 has an average financial health and profitability rating. NZM2 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
NZM2 had positive earnings in the past year.
In the past year NZM2 had a positive cash flow from operations.
Each year in the past 5 years NZM2 has been profitable.
Each year in the past 5 years NZM2 had a positive operating cash flow.
1.2 Ratios
NZM2 has a Return On Assets (1.86%) which is comparable to the rest of the industry.
NZM2 has a Return On Equity (2.85%) which is in line with its industry peers.
NZM2 has a Return On Invested Capital (3.27%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for NZM2 is above the industry average of 7.19%.
The 3 year average ROIC (11.83%) for NZM2 is well above the current ROIC(3.27%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.86% | ||
| ROE | 2.85% | ||
| ROIC | 3.27% |
ROA(3y)8.6%
ROA(5y)10.46%
ROE(3y)16.98%
ROE(5y)20.54%
ROIC(3y)11.83%
ROIC(5y)13.54%
1.3 Margins
The Profit Margin of NZM2 (7.98%) is better than 72.46% of its industry peers.
In the last couple of years the Profit Margin of NZM2 has declined.
The Operating Margin of NZM2 (17.19%) is better than 89.86% of its industry peers.
NZM2's Operating Margin has declined in the last couple of years.
NZM2's Gross Margin of 47.20% is fine compared to the rest of the industry. NZM2 outperforms 68.12% of its industry peers.
NZM2's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.19% | ||
| PM (TTM) | 7.98% | ||
| GM | 47.2% |
OM growth 3Y-13.18%
OM growth 5Y-7.58%
PM growth 3Y-27.63%
PM growth 5Y-18.32%
GM growth 3Y-6.52%
GM growth 5Y-3.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NZM2 is still creating some value.
Compared to 1 year ago, NZM2 has more shares outstanding
NZM2 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NZM2 has been reduced compared to a year ago.
2.2 Solvency
NZM2 has an Altman-Z score of 3.77. This indicates that NZM2 is financially healthy and has little risk of bankruptcy at the moment.
NZM2's Altman-Z score of 3.77 is fine compared to the rest of the industry. NZM2 outperforms 76.81% of its industry peers.
The Debt to FCF ratio of NZM2 is 5.84, which is a neutral value as it means it would take NZM2, 5.84 years of fcf income to pay off all of its debts.
NZM2 has a Debt to FCF ratio of 5.84. This is in the better half of the industry: NZM2 outperforms 69.57% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that NZM2 is not too dependend on debt financing.
NZM2 has a Debt to Equity ratio of 0.28. This is in the better half of the industry: NZM2 outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 5.84 | ||
| Altman-Z | 3.77 |
ROIC/WACC0.48
WACC6.83%
2.3 Liquidity
A Current Ratio of 1.75 indicates that NZM2 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.75, NZM2 perfoms like the industry average, outperforming 53.62% of the companies in the same industry.
A Quick Ratio of 1.07 indicates that NZM2 should not have too much problems paying its short term obligations.
NZM2 has a Quick ratio (1.07) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
NZM2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -54.37%.
NZM2 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -42.95% yearly.
NZM2 shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.85%.
The Revenue for NZM2 have been decreasing by -23.23% on average. This is quite bad
EPS 1Y (TTM)-54.37%
EPS 3Y-23.83%
EPS 5Y-42.95%
EPS Q2Q%108.93%
Revenue 1Y (TTM)59.85%
Revenue growth 3Y24.12%
Revenue growth 5Y-23.23%
Sales Q2Q%-44.4%
3.2 Future
Based on estimates for the next years, NZM2 will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.54% on average per year.
NZM2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.81% yearly.
EPS Next Y41.09%
EPS Next 2Y24.82%
EPS Next 3Y19.64%
EPS Next 5Y16.54%
Revenue Next Year5.64%
Revenue Next 2Y6.18%
Revenue Next 3Y6.45%
Revenue Next 5Y6.81%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 81.61 indicates a quite expensive valuation of NZM2.
NZM2's Price/Earnings ratio is a bit more expensive when compared to the industry. NZM2 is more expensive than 63.77% of the companies in the same industry.
NZM2's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
With a Price/Forward Earnings ratio of 26.86, NZM2 can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NZM2 indicates a slightly more expensive valuation: NZM2 is more expensive than 66.67% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of NZM2 to the average of the S&P500 Index (22.94), we can say NZM2 is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 81.61 | ||
| Fwd PE | 26.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NZM2 is valued a bit more expensive than 71.01% of the companies in the same industry.
NZM2's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.85 | ||
| EV/EBITDA | 20.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NZM2 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of NZM2 may justify a higher PE ratio.
A more expensive valuation may be justified as NZM2's earnings are expected to grow with 19.64% in the coming years.
PEG (NY)1.99
PEG (5Y)N/A
EPS Next 2Y24.82%
EPS Next 3Y19.64%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.58%, NZM2 has a reasonable but not impressive dividend return.
NZM2's Dividend Yield is comparable with the industry average which is at 3.23.
Compared to the average S&P500 Dividend Yield of 2.36, NZM2 is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.58% |
5.2 History
The dividend of NZM2 decreases each year by -33.21%.
Dividend Growth(5Y)-33.21%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
NZM2 pays out 126.65% of its income as dividend. This is not a sustainable payout ratio.
DP126.65%
EPS Next 2Y24.82%
EPS Next 3Y19.64%
FRA:NZM2 (10/17/2025, 7:00:00 PM)
54.68
+0.06 (+0.11%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners45.55%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap22.67B
Analysts74.55
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.58% |
Yearly Dividend0.67
Dividend Growth(5Y)-33.21%
DP126.65%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.2%
Min EPS beat(2)6.35%
Max EPS beat(2)14.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.34%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 81.61 | ||
| Fwd PE | 26.86 | ||
| P/S | 5.91 | ||
| P/FCF | 39.85 | ||
| P/OCF | 24.68 | ||
| P/B | 2.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.35 |
EPS(TTM)0.67
EY1.23%
EPS(NY)2.04
Fwd EY3.72%
FCF(TTM)1.37
FCFY2.51%
OCF(TTM)2.22
OCFY4.05%
SpS9.25
BVpS25.91
TBVpS-1.12
PEG (NY)1.99
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.86% | ||
| ROE | 2.85% | ||
| ROCE | 4.33% | ||
| ROIC | 3.27% | ||
| ROICexc | 3.35% | ||
| ROICexgc | 13.61% | ||
| OM | 17.19% | ||
| PM (TTM) | 7.98% | ||
| GM | 47.2% | ||
| FCFM | 14.84% |
ROA(3y)8.6%
ROA(5y)10.46%
ROE(3y)16.98%
ROE(5y)20.54%
ROIC(3y)11.83%
ROIC(5y)13.54%
ROICexc(3y)18.53%
ROICexc(5y)19.75%
ROICexgc(3y)31.27%
ROICexgc(5y)31.83%
ROCE(3y)15.67%
ROCE(5y)17.93%
ROICexcg growth 3Y-32.98%
ROICexcg growth 5Y-9.18%
ROICexc growth 3Y-47.62%
ROICexc growth 5Y-27.9%
OM growth 3Y-13.18%
OM growth 5Y-7.58%
PM growth 3Y-27.63%
PM growth 5Y-18.32%
GM growth 3Y-6.52%
GM growth 5Y-3.21%
F-Score6
Asset Turnover0.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 5.84 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 58.5% | ||
| Cap/Sales | 9.12% | ||
| Interest Coverage | 8.55 | ||
| Cash Conversion | 73.09% | ||
| Profit Quality | 186% | ||
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 3.77 |
F-Score6
WACC6.83%
ROIC/WACC0.48
Cap/Depr(3y)134.29%
Cap/Depr(5y)112.94%
Cap/Sales(3y)12.45%
Cap/Sales(5y)10.47%
Profit Quality(3y)105.18%
Profit Quality(5y)105.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-54.37%
EPS 3Y-23.83%
EPS 5Y-42.95%
EPS Q2Q%108.93%
EPS Next Y41.09%
EPS Next 2Y24.82%
EPS Next 3Y19.64%
EPS Next 5Y16.54%
Revenue 1Y (TTM)59.85%
Revenue growth 3Y24.12%
Revenue growth 5Y-23.23%
Sales Q2Q%-44.4%
Revenue Next Year5.64%
Revenue Next 2Y6.18%
Revenue Next 3Y6.45%
Revenue Next 5Y6.81%
EBIT growth 1Y10.18%
EBIT growth 3Y7.76%
EBIT growth 5Y-29.04%
EBIT Next Year67.21%
EBIT Next 3Y25.74%
EBIT Next 5Y18.32%
FCF growth 1Y-7.51%
FCF growth 3Y20.37%
FCF growth 5Y-21.39%
OCF growth 1Y-71.73%
OCF growth 3Y23.25%
OCF growth 5Y-20.42%